Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing Charles River's immunology expertise to refine study paramet ...

Royalty Pharma plc (Nasdaq: RPRX) today announced that it has entered into an agreement with Biogen to provide research and development (R&D) funding of up ...

Multiple sclerosis and lupus can have some overlapping symptoms, but they’re two distinct conditions. Read on to find out more about common symptoms and possible treatments. Multiple sclerosis ...

Patient enrollment is ongoing in the Phase 1 study of ADI-001 for the treatment of lupus nephritis (LN). Patient enrollment in SLE, systemic sclerosis (SSc), idiopathic inflammatory myopathy ...

Additionally, enrollment for the Phase 2 SunStone trial in systemic lupus erythematosus is anticipated to complete in 2025. The company is well-positioned financially, ending 2024 with ...

Systemic lupus erythematosus (SLE) can involve many parts of the eye, including the eyelid, ocular adnexa, sclera, cornea, uvea, retina and optic nerve. Ocular manifestations of SLE are common and may ...

Al Shifa Hospital, the largest in Gaza, can no longer accommodate the growing number of patients. Its severely damaged infrastructure has become a symbol of the health system's collapse. Al Shifa, ...

"The sacrifices of these colleagues will remain a lasting symbol of the struggle for freedom of the press and the right to expression," the statement read. Enab Baladi later established itself in ...

Ascentage’s Wall Street debut is a test of U.S. investors’ interest in the progress China’s biotech sector has made. Efforts by the Chinese government to boost the country’s capabilities have produced ...